* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download formulation and evalution of medicated chewing gum of
Orphan drug wikipedia , lookup
Pharmaceutical marketing wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Compounding wikipedia , lookup
Zoopharmacognosy wikipedia , lookup
Theralizumab wikipedia , lookup
Neuropharmacology wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Drug design wikipedia , lookup
Nicholas A. Peppas wikipedia , lookup
Drug interaction wikipedia , lookup
Drug discovery wikipedia , lookup
Prescription costs wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
“FORMULATION AND EVALUTION OF MEDICATED CHEWING – GUM OF CINNARIZINE” MASTER OF PHARMACY DISSERTATION PROTOCOL SUBMITTED TO THE RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES KARNATAKA, BANGALORE. BY KOTHARI PALAK MAHESHKUMAR M.Pharm-Ι UNDER THE GUIDANCE Dr. Harish N.M. M. Pharm.,Ph.D. ASSOCIATE PROFESSOR DEPARTMENT OF INDUSTRIAL PHARMACY SRINIVAS COLLEGE OF PHARMACY, VALACHIL, MANGALORE – 574143. 2012-2013 (MID STREAM BATCH) RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCE BANGALORE, KARNATAKA ANNEXURE-II PROFORMA FOR REGISTRATION OF SUBJECTS FOR DISSERTATION 1. Name of the Candidate and Mr. KOTHARI PALAK MAHESHKUMAR Address: 1st YEAR M.PHARM, DEPT. OF INDUSTRIAL PHARMACY, SRINIVAS COLLEGE OF PHARMACY VALACHIL, MANGALORE-574143. SRINIVAS COLLEGE OF PHARMACY 2. VALACHIL, FARANGIPETE POST, MANGALORE- Name of the Institution: 574143. 3. Course of Study and Subject: MASTER OF PHARMACY (INDUSTRIAL PHARMACY) 4. Date of Admission: 5. Title of the Project: 10/01/2013 “FORMULATION AND EVALUTION OF MEDICATED CHEWING GUM OF CINNARIZINE” 6. Brief Resume of the intended work: 6.1 Need of the study: Pharmacologically active Agents or Drugs are formulated into variety of dosage forms like Tablets, Injectable, Ointments, etc. considering physicochemical properties, pharmacokinetics and pharmacodynamics parameters and biopharmaceutical aspects of Drugs; however, recently in addition to its confectionary role, chewing gum also has proven great value as a delivery vehicle for pharmaceutical and nutraceutical ingredients. Many therapeutic agents are absorbed in the oral cavity. For the drugs having significant buccal absorption, dosage forms such as Lozenges, Chewable tablets and Chewing gum permits more rapid therapeutic action compared to per-oral dosage forms. Chewing gum today is considering as a delivery system to administer active principle that can improve health and nutrition1. During the chewing gum process, most of the drug products are released into the saliva and either absorbed through buccal mucosa or swallowed through GIT2. Chewing Gum has been used for centuries to clean the mouth and freshen breath. Medicated Chewing Gums are solid, single dose preparations with a base consisting mainly of gum that is intended to be chewed but not swallowed. They contain one or more active substance which released by chewing and are to be used for local treatment diseases of oral cavity as well as treatment of systemic condition3. This drug delivery system offers two absorption pathways. Drug absorbed via the buccal membrane avoids metabolism in the gastrointestinal tract and thus the chance of first pass effect of the liver4. Since it can be taken anywhere, a chewing gum formulation is an excellent choice for medication5. Cinnarizine is [1-benzhydryl-4-cinnamyl-piperazine] with half-life of 3-4 hours, It is an antivertigo drug,and is also protective for motion sickness. It probably acts by inhibiting infux of ca2+ from endolymph into the vestibular cells which medicates labyrinthine reflexes 6-7. In the present work an attempt has been made to Design and evaluate medicated chewing gum of Cinnarizine for the effective management of motion sickness. Advantages of Medicated Chewing Gums8: 1. Dose not requires water to swallow. Hence can be take anywhere. 2. Advantageous for patients having difficulty in swallowing. 3. Excellent for acute medication. 4. Counteracts dry mouth, prevents candidacies and caries. 5. Avoids First Pass Metabolism and thus increases the bioavailability of drugs. 6. Fast onset due to rapid release of active ingredients in buccal cavity and subsequent absorption in systemic circulation. 7. Gum does not reach the stomach. Hence G.I.T. suffers less from the effects of excipients. 8. Stomach does not suffer from direct contact with high concentrations of active principles, thus reducing the risk of intolerance of gastric mucosa 9. Fraction of product reaching the stomach is conveyed by saliva delivered continuously and regularly. Duration of action is increased. Commercially available medicated chewing gums9 Trade mark Active substance Aim Commercially Available Aspergum Asprin Pain relief North America NIcorette Nicotine Smoking Cessation World wide Brain DHA and CCE Enhanced Japan brain activity Stami Vitamin c Vitamin c General health Australia Vitamin Vitamin c General health Australia Stay alert Caffine Alertness USA,Japan Café Coffe Caffine Alertness Japan Travel Dimenhydrimate Motion Scikness USA, Australia V6 Xylitol Prevention of formulation of dental USA, Australia caries Fluorette FLuoride Canostatic USA 6.2 – Review of literature: The literature survey on Medicated Chewing Gum is carried out by referring various scientific journals, internet and helinet facility. Farhad M, Piyush T10 had formulated and Charaterised Natural biodegradable Chewing Gum of corn zein. Corn zein as a gum base offers nonadhesive and biodegradable property.Various plasticizer are used for formulation of corn zein gum. The study shows corn zein is best suited to be used as biodegadable gum base which can be developed as acceptable product for consumers. Farhad M, Piyush T11 had formulated and characterised texture of medicated chewing gum delivery of Dimenhydrinate Hydrochloride for the treatment of nausea occurs immediately or with very short warning. Shivanand P, Manish G, Viral D12 had studied the Development, in-vitro evaluation and physical characterization of medicated chewing gum using Chlorhexidine Gluconate and concluded that in concentration of 50% synthetic gum base gives promising result with the water soluble drug Chlorhexidine gluconate for steady release. Rajnikanth V, Seth AK, Sachin C, Parth P, Pratik K, Chainesh S et al.13 Formulated and evaluated novel gum base drug delivery system of an antiemetic (Meclizine hydrochloride) drug prepared by direct compression method and where characterized by pre-compression character, post compression character, buccal absorption study, drug content and in-vitro release studies. Shivang AC,Alisagar FS14 had formulated and evaluated medicated chewing gum of cetrizine for quick relief of common cold by using elastomer,softners,bulking agents and chew out test was carried out by in vitro drug release studies.The studies showed that salivary dilution and invoulantry swallowing are the main resons for in variability in absorption rates. Gunjal PR, Kalmegh TS, Gadhave M, Jadhav S15 has reviewed on Medicated chewing gum as Novel drug delivery system and concluded that Chewing gum is an excellent drug delivery system for self-medication. Patel Y, Shukla A, Saini V, Sharma P16 studied about Chewing Gum as a Drug delivery system holds tremendous potential not only in smoking cessation and oral care areas but also in other indications. Upendra RM, Prasanthi G, Ramesh Y17 has formulated and evaluated medicated chewing gum of promethazine hydrochloride using polyvinyl pyrrolidone synthetic sgum and glycerol & castor oil as plasticiser and concluded that using castor oil as plasticiser gives better release of drug than glycerol. Yamini M,William JI, Paul XB, Rick SC, Barbara RC18 had studied release of nicotine from conventional gums and from gums made using a directly compressible gum base was studied using the European Pharmacopoeia apparatus for testing of medicated chewing gums.It was found that gum base and the method of preparation used in a formulation were important factors when controlling the release of drugs from chewing gum. 6-3 OBJECTIVES OF THE STUDY: 1. To formulate the medicated chewing gum containing Cinnarizine for the treatment of motion sickness. 2. To check drug-excipient compatibility by FTIR. 3. To evaluate the physical characteristics of formulated medicated chewing gum. 4. To study the drug release profile. 5. To carry out stability studies for the formulated chewing gums as per ICH guidelines. Materials and Methods: Materials: Drug : Cinnarizine. Ingredients : Gum base, Polyvinyl pyrrolidine, Glycerol, Fillers, Sodium Carbonate anhydrous, Flavours, etc. All other materials used will be of analytical grade. Methods: Any one of following method mention as below. Different methods can be employed for the manufacturing of chewing Gum can be broadly classified into three main classes namely: Conventional/Traditional method19. Freezing, Grinding and Tableting method19. Direct compression method19. 7. 7.1 Source of data: 1. Review of literature from • Journals such as International Journal of ChemTech Research International Journal of Pharma Professional’s Research Journal of Chemical and Pharmaceutical Research Indian Journal of Pharmaceutical Sciences Journal of Global Pharma Technology International Journal of Pharmaceutical Sciences Review and Research International Journal of Pharmacy and Pharmaceutical Sciences Journal of Pharma Research • Internet Browsing. • Laboratory based studies. 2. Laboratory based experiments and evaluation. 7.2 – Method of Collection of Data: • An Overview of Medicated Chewing Gum. • Formulation of Medicated chewing gum of Cinnarizine. • Preformulation Studies:- • Purity of drug by FTIR • pH • Melting point • Lambda max. • Evaluation of formulated cinnarizine medicated chewing gums, as follows12: Pre-compression characteristics. Bulk density. Tapped density. Compressibility index. Hausner’s ratio. Angle of repose. Post-compressional characterisation. Hardness. Weight variation. Estimation of drug content. In-vitro drug release studies. To carry out stability study as per ICH guidelines. 7.3 Does the study require any investigations or interventions to be conducted on patients or other humans or animals? If so, please describe briefly. - NOT APPLICABLE 7.4 Has ethical clearance been obtained from your institution in case of 7.3? - NOT APPLICABLE 8.0 List of references: 1. Nilam T, Karishma P. A review on medicated chewing gum as a novel drug delivery system. J Pharm Res 2011; 4(3):848-51. 2. Asija R, Patel S, Asija S. Oral dosage form Medicine containing chewing gum: A review. J Drug Del Thera 2012; 2(6):90-105. 3. Basani G, Venkata RD, Madhusudan YR. Medicated chewing gum-A novel approach to improve patient compliance. Int J Res Pharm Bio Sci 2011; 2(1):23-32. 4. Sabera K, Bishwajit KS. Medicated chewing gum: An unconventional drug delivery system. Int Curr Pharm J 2012; 1(4):86-91. 5. Ezhumalai E, Ilavarasan P, Rajalakshmi AN, Sathiyaraj U, Murali RM. Medicated chewing gum-A novel drug delivery technique for systemic and targeted drug delivery. Int J Pharm Tech 2011; 3(1):725-44. 6. Cinnarizine Drug Bank. www.drugbank.ca/drugs/DB00568. 7. Tripathi K.D. Essentials of medical pharmacology,6th edition:pg.no-642. 8. Shashank N,Shweta K,Srinivas H,Ramkrishna S.Medicated chewin gum:A boon to oral dosage forms.Am.J.PharmTch Res.2012;2(6):150-61. 9. Vilcy PW,Milind T. A comprehensive review on:Medicated chewing gum.Int.J.of Res. Pharm Biomed sci.2012;3(2):894-907 . 10. Farhad M,Piyush T. Formulation And Characterization Of Natural Biodegradable Chewing Gum.Int J Pharm Tech Res 2012;4(3):889-99. 11. Farhad M, Piyush T. Formulation and texture characterization of medicated chewing gum delivery of Dimenhydrinate Hydrochloride. Sch Res Lib 2011; 3(6):179-92. 12. Shivanand P, Manish G, Viral D. Development, in-vitro evaluation and physical characterization of medicated chewing gum: Chlorohexidine Gluconate. Sch Res Lib 2009; 1(2): 286-92. 13. Rajnikanth V, Seth AK, Sachin C, Parth P, Pratik K, Chainesh S et al., Formulation and evaluation of novel gum based drug delivery system of an antiemetic drug. Int J Pharm Res Tech 2012; 2(2):16-20. 14. Shivang AC, Alisagar FS. Directly compressible medicated chewing gum for quick relief of common cold Int J Pharm Inve 2012;2(3):123-33. 15. Gunjal PR, Kalmegh TS, Gadhave M, Jadhav S. A review on medicated chewing gum as a novel drug delivery system. Int J Uni Pharm L Sci 2012; 2(4):194-206. 16. Patel Y, Shukla A, Saini V, Sharma P. Chewing gum as a drug delivery system. Int J Pharm Sci Res 2011; 2(4):748-57. 17. Upendra RM, Prasanthi G, Ramesh Y. Formulation and evaluation of medicated chewing gum of Promethazine hydrochloride. J Pharm Res 2011; 4(9):3247-50. 18. Yamini M,William JI, Paul XB, Rick SC, Barbara RC.In vitro release of nicotine from chewing gum formu Diss tech 2004:12-15. 19. Pratik S, Asif K, Ramana MV, Mitul P, Mahesh K. Chewing gum: A modern era of drug delivery. Int Res J Pharm 2011; 2(10):07-12. 9. Signature of the candidate (KOTHARI PALAK MAHESHKUMAR) 10. Remarks of the Guide The work, which is assigned to Mr. KOTHARI PALAK MAHESHKUMAR is under my guidance. DR.HARISH N.M.M.PHARM,Ph.D. Associate professor 11. 11.1 Name and Designation of Department of industrial pharmacy, Srinivas college of Pharmacy the Guide Valachil, Mangalore-574143. 11.2 Signature 11.3 Head of the Department Dr. HARSH N.M.M.Pharm., Ph.D. HOD Department of Industrial Pharmacy Srinivas College of Pharmacy, Valachil, Mangalore- 574143 11.4 Signature 12. 12.1 Remarks of the Principal Recommended and forwarded for favourable consideration. Dr. A. R. SHABARAYAM.Pharm., Ph.D. 12.2 Signature Principal and Director Srinivas College of Pharmacy, Valachil, Mangalore- 574143